Find your path to John
About
Venture Partner since 2024 with over 25 years in biotech and pharma. He was most recently CEO of Atreca and serves as Executive Chair of Agni Bio and board chair of Synthekine, and previously led Genentech's BioOncology Business Unit.
Experience
- Samsara BioCapitalVenture Partnercurrent2024 — presentPalo Alto, California, United States
- Nested TherapeuticsChairman of the Boardcurrent2024 — present
- AnaptysBioChairman of the Boardcurrent2023 — presentSan Diego, California, United States
- Travere TherapeuticsBoard Membercurrent2017 — present
- CARGO TherapeuticsChairman of the Board2022 — 2025San Mateo, CA
- Atreca, Inc.President and CEO2018 — 2024San Carlos, California, United States
- Seattle GeneticsBoard Member2014 — 2023
- Array BioPharma Inc.Board Member2012 — 2019
- RelypsaPresident and CEO2013 — 2017Redwood City, CA
- AffymaxPresident and CEO2010 — 201394034
- GenentechSenior Vice President, BioOncology2005 — 2010South San Francisco, CA
- Johnson & JohnsonFranchise Vice President, Tibotec Therapeutics2001 — 2004Bridgewater, NJ
- Rhone-Poulenc RorerMarketing Director1994 — 1998
- Schering PloughSenior Product Manager1989 — 1994
Skills & more
Strategy1Biotechnology1Clinical DevelopmentDrug DevelopmentOperational PlanningPharmaceutical IndustryR&DAcquisitionsMarketingSales Operations
From John's professional profile.
Colleagues at Samsara BioCapital
Abe Bassan
Principal at Samsara BioCapital
Alan Eisenberg
Venture Partner at Samsara BioCapital
Andrew Walker
Assistant Controller at Samsara BioCapital
Betsy Santos
Venture Partner, Chief People Officer at Samsara BioCapital
Carolyn Nguyen
Deputy General Counsel at Samsara BioCapital
Clara Dong
Senior Associate at Samsara BioCapital
Connie Su
Senior Fund Accountant at Samsara BioCapital
Cory Freedland
Investor at Samsara BioCapital
Frequently asked questions
- Who is John Orwin?
- Venture Partner since 2024 with over 25 years in biotech and pharma. He was most recently CEO of Atreca and serves as Executive Chair of Agni Bio and board chair of Synthekine, and previously led Genentech's BioOncology Business Unit.
- Where does John Orwin work?
- John Orwin is Venture Partner at Samsara BioCapital.
- Where did John Orwin go to school?
- John Orwin studied at NYU Stern School of Business (Master of Business Administration (MBA), International Business & Finance); Rutgers University (Bachelor of Arts (B.A.), Economics).
Same school
Also attended NYU Stern School of Business829
Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsMax WechterSenior Director of AI at Lerer HippeauTom MonahanFormer Chairman & CEO, CEB at MissionOGKrupa VankayalaPartner, People & HR at Sapphire Ventures
+ 823 more
Also attended Rutgers University311
Jigar RaythathaInvestor at Third Rock VenturesRobin LiInvestor at GGV CapitalDominique LittleGovernment Affairs Lead at ParadigmGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersBill DeJianneSales Manager (Eastern U.S.) at Needham FundsMark FieldsInvestor at Alsop Louie Partners
+ 305 more
Shared employers
Also worked at Travere Therapeutics4
Also worked at Seattle Genetics12
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Doug WilliamsBiotech Executive & Founding Pillar at Pillar VCLouis BockVenture Partner at Sante VenturesDr. Guy PadburySVP, Oncology Clinical Pharmacology at Illinois VenturesNeela PatelExecutive Officer at Bonum TherapeuticsRoland GendronChief Business Officer at Stipple Bio
+ 6 more
Also worked at Array BioPharma Inc.8
Steve TregayManaging General Partner at Mission BiocapitalLarry BurgessExecutives in Residence at GENERAL INCEPTIONKyle LefkoffGeneral Partner at Boulder VenturesJohn JoseyPartner at The Column GroupJoey MoneyLife Sciences Client Manager at Innosphere VenturesDylan HartleyExecutive Officer at Onkure Therapeutics Inc
+ 2 more
Also worked at Affymax6
Krishna PoluPrincipal at Red Tree VentureHelen KimPartner at The Column GroupTed W. LoveExecutive Officer, Director at Global Blood TherapeuticsKarin L. WalkerExecutive Officer at ProthenaArlene MorrisExecutive Officer, Director at Syndax PharmaceuticalsCamille LandisChief Business Officer / Chief Financial Officer at T-Knife












































